Literature DB >> 23230187

Integrative cancer epidemiology--the next generation.

Margaret R Spitz1, Neil E Caporaso, Thomas A Sellers.   

Abstract

We outline an integrative approach to extend the boundaries of molecular cancer epidemiology by integrating modern and rapidly evolving "omics" technologies into state-of-the-art molecular epidemiology. In this way, one can comprehensively explore the mechanistic underpinnings of epidemiologic observations in cancer risk and outcome. We highlight the exciting opportunities to collaborate across large observational studies and to forge new interdisciplinary collaborative ventures. ©2012 AACR.

Entities:  

Mesh:

Year:  2012        PMID: 23230187      PMCID: PMC3531829          DOI: 10.1158/2159-8290.CD-12-0424

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  27 in total

1.  The beginning of the end for the epidemiologic focus on gene-environment interactions?

Authors:  Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

2.  Integrative study designs--next step in the evolution of molecular epidemiology?

Authors:  Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

3.  Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies--challenges and opportunities.

Authors:  Muin J Khoury; Sholom Wacholder
Journal:  Am J Epidemiol       Date:  2008-11-20       Impact factor: 4.897

4.  Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.

Authors:  Shuji Ogino; Emily E King; Andrew H Beck; Mark E Sherman; Danny A Milner; Edward Giovannucci
Journal:  Am J Epidemiol       Date:  2012-08-30       Impact factor: 4.897

Review 5.  Integrative epidemiology: from risk assessment to outcome prediction.

Authors:  Margaret R Spitz; Xifeng Wu; Gordon Mills
Journal:  J Clin Oncol       Date:  2005-01-10       Impact factor: 44.544

6.  Landmarks in the history of cancer epidemiology.

Authors:  Peter Greenwald; Barbara K Dunn
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Molecular cancer epidemiology: a new tool in cancer prevention.

Authors:  F P Perera
Journal:  J Natl Cancer Inst       Date:  1987-05       Impact factor: 13.506

Review 8.  Opportunities and barriers in the age of team science: strategies for success.

Authors:  Thomas A Sellers; Neil Caporaso; Stan Lapidus; Gloria M Petersen; Jeff Trent
Journal:  Cancer Causes Control       Date:  2006-04       Impact factor: 2.506

Review 9.  Can genes for mammographic density inform cancer aetiology?

Authors:  Linda E Kelemen; Thomas A Sellers; Celine M Vachon
Journal:  Nat Rev Cancer       Date:  2008-09-05       Impact factor: 60.716

10.  T (brachyury) gene duplication confers major susceptibility to familial chordoma.

Authors:  Xiaohong R Yang; David Ng; David A Alcorta; Norbert J Liebsch; Eamonn Sheridan; Sufeng Li; Alisa M Goldstein; Dilys M Parry; Michael J Kelley
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

View more
  23 in total

1.  Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.

Authors:  Suliman Y Alomar; Afrah Alkhuriji; Paul Trayhyrn; Abdulkarim Alhetheel; Abdullah Al-Jurayyan; Lamjed Mansour
Journal:  Immunogenetics       Date:  2016-09-15       Impact factor: 2.846

2.  Charting a future for epidemiologic training.

Authors:  Ross C Brownson; Jonathan M Samet; Gilbert F Chavez; Megan M Davies; Sandro Galea; Robert A Hiatt; Carlton A Hornung; Muin J Khoury; Denise Koo; Vickie M Mays; Patrick Remington; Laura Yarber
Journal:  Ann Epidemiol       Date:  2015-03-14       Impact factor: 3.797

Review 3.  Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints.

Authors:  Tram Kim Lam; Sheri D Schully; Scott D Rogers; Rachel Benkeser; Britt Reid; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-14       Impact factor: 4.254

4.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Authors:  Shuji Ogino; Reiko Nishihara; Tyler J VanderWeele; Molin Wang; Akihiro Nishi; Paul Lochhead; Zhi Rong Qian; Xuehong Zhang; Kana Wu; Hongmei Nan; Kazuki Yoshida; Danny A Milner; Andrew T Chan; Alison E Field; Carlos A Camargo; Michelle A Williams; Edward L Giovannucci
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

Review 5.  The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists.

Authors:  Margaret R Spitz; Tram Kim Lam; Sheri D Schully; Muin J Khoury
Journal:  Am J Epidemiol       Date:  2014-09-18       Impact factor: 4.897

Review 6.  Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.

Authors:  Paul Lochhead; Andrew T Chan; Reiko Nishihara; Charles S Fuchs; Andrew H Beck; Edward Giovannucci; Shuji Ogino
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

Review 7.  Transdisciplinary approaches enhance the production of translational knowledge.

Authors:  Timothy H Ciesielski; Melinda C Aldrich; Carmen J Marsit; Robert A Hiatt; Scott M Williams
Journal:  Transl Res       Date:  2016-11-10       Impact factor: 7.012

8.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Authors:  Clare Abbenhardt; Elizabeth M Poole; Richard J Kulmacz; Liren Xiao; Karen Curtin; Rachel L Galbraith; David Duggan; Li Hsu; Karen W Makar; Bette J Caan; Lisel Koepl; Robert W Owen; Dominique Scherer; Christopher S Carlson; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

Review 9.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Authors:  Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

10.  Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

Authors:  Shuji Ogino; Xiaoyun Liao; Yu Imamura; Mai Yamauchi; Nadine J McCleary; Kimmie Ng; Donna Niedzwiecki; Leonard B Saltz; Robert J Mayer; Renaud Whittom; Alexander Hantel; Al B Benson; Rex B Mowat; Donna Spiegelman; Richard M Goldberg; Monica M Bertagnolli; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2013-11-14       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.